Dogwood Therapeutics, Inc. Temporary Equity, Carrying Amount, Attributable to Parent
Dogwood Therapeutics, Inc. (DWTX) had Temporary Equity, Carrying Amount, Attributable to Parent of $70.13 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Equity › Temporary Equity
us-gaap:TemporaryEquityCarryingAmountAttributableToParent · last filed 2026-03-18
- 2025-09-30: Temporary Equity, Carrying Amount, Attributable to Parent $70.13M.
- 2025-06-30: Temporary Equity, Carrying Amount, Attributable to Parent $75.66M.
- 2025-03-31: Temporary Equity, Carrying Amount, Attributable to Parent $75.66M.
- 2024-12-31: Temporary Equity, Carrying Amount, Attributable to Parent $74.41M.
| Period end | Temporary Equity, Carrying Amount, Attributable to Parent |
|---|---|
| 2025-09-30 | $70.13M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $75.66M 10-Q · filed 2025-11-07 |
| 2025-03-31 | $75.66M 10-Q · filed 2025-11-07 |
| 2024-12-31 | $74.41M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |